Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Johnson & Johnson’s JNJ stock has risen 16.7% in the past three months. A lot of this price increase is due to strong third-quarter 2025 results, where in both the top and bottom lines exceeded ...

OAKMONT, Pa. — On the Oakmont Country Club range, about an hour or so ahead of a most consequential afternoon, J.J. Spaun’s white golf bag with red and black trim sat, and he and his caddie, Mark ...

The Johnson & Johnson JNJ stock has risen 4.4% in six months, adding more than $15 billion to its market value. J&J faces several challenges, including slowing sales in the MedTech segment, loss of ...

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 to 24 months, marking its second major spinoff in two years as it sharpens ...

Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian ...

The Watt family's 2020 Thanksgiving will be different, but not for the reasons you'd think. And that was before the rescheduling All three Watt brothers — J.J., Derek and T.J. — were supposed to be ...